Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyCareSource Medical Benefit Drugs Prior Auth | Open…
    Ask Trek AI about this page
    CurrentCareSourcePolicy PAD-0898-AR-PASSE

    Medical Benefit Drugs administrative policy

    Customize your policy alerts

    Sign up for CareSource Policy PAD-0898-AR-PASSE alerts

    Get alerted when Policy PAD-0898-AR-PASSE changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs prior authorization, documentation, site-of-care, and reauthorization requirements for medications billed to the medical benefit for CareSource members (Arkansas PASSE context). Affects providers requesting coverage for medical benefit medications.

    Policy Summary
    PayerCareSource
    PolicyMedical Benefit Drugs administrative policy
    Policy CodePolicy PAD-0898-AR-PASSE
    Change TypeNo material change
    Effective DateJul 1, 2026
    Last ReviewFeb 18, 2026
    Next Review Date
    Key ActionSubmit prior authorization requests with chart notes and member-specific documentation for each Medical Benefit Drug.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    prior authorization requiredPA requirement
    generally not coveredSelf-administered presumption
    positive response & complianceReauthorization
    uses PDL/PAD criteriaPDL/PAD

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Medical Necessity and Coverage Criteria

    Medical Necessity Criteria

    CareSource considers a Medical Benefit Drug medically necessary when ALL of the following criteria are met:

    ALL of the following

    • Prior Authorization with chart notes and member-specific documentation submitted
    • Indication, dose, and duration are FDA-approved or supported by compendia, current peer-reviewed literature, or evidence-based guidelines
    • ONE of

      • Requested drug is a CareSource Preferred Drug
      • Member is unable to take Preferred Drug(s) because there is no suitable Preferred drug or needed dosage form for the diagnosis
      • Preferred Drug(s) are not recommended based on published guidelines or clinical literature
      • Preferred Drug(s) are expected to be ineffective or less effective for the member based on submitted documentation and medical history
      • Preferred Drug(s) are expected to cause an adverse effect for the member based on submitted documentation and medical history

    ALL of the following

    • If requested agent has a self-administered dosage form available, include rationale why member cannot utilize the self-administered version (self-administered drugs are generally not covered under the medical benefit)
    • If managed under Arkansas PDL or PAD program, apply those criteria

    ALL of the following

    • Documentation that the drug will be administered in the appropriate site of care
    • For reauthorization, documentation of positive response, compliance, and dosing consistent with FDA labeling is required

    Coding References

    Coding referencemixed
    No codes listed

    Prior Authorization, Authorization Period, and Reauthorization

    Prior Authorization

    Prior Authorization and Review

    Submit a Prior Authorization request for each Medical Benefit Drug including chart notes and member-specific documentation; approvals may require pharmacist and/or medical director review.

    • Include indication, dose, and duration documentation showing FDA approval or support from compendia/peer-reviewed literature/guidelines.
    • If a self‑administered dosage form exists, include rationale why the member cannot use it (self‑administered drugs are generally not covered under the medical benefit).
    Documentation Required

    Authorization Period Determination

    The authorization period is set by the approving pharmacist using clinical judgement.

    Prior Authorization

    Reauthorization Requirements

    For reauthorization, provide documentation showing a positive response to therapy, member compliance, and that the requested use and dosage remain consistent with FDA‑approved prescribing information.

    • Documentation of positive clinical response to the drug.
    • Documentation of adherence/compliance with the prescribed therapy.
    • Current dosing and indication must match FDA‑approved prescribing information in the package insert.

    Definitions

    Medical Benefit Drug — definition
    DefinitionA drug usually administered by a healthcare provider or in a supervised healthcare setting and billed to CareSource through the medical benefit; subject to applicable member cost share per the Schedule of Benefits (SOB) and/or Summary of Benefits and Coverage (SBC).
    Administration settingTypically given by a provider or in a supervised healthcare setting (e.g., infusion center).
    Billing pathwayBilled to CareSource under the medical benefit rather than the pharmacy benefit.
    Cost shareSubject to member cost share as specified in the SOB and/or SBC.
    Clinical Judgement — definition
    DefinitionDecisions made within the scope and expertise of a pharmacist following review of subjective and objective medical data for a member.
    ScopePharmacists may use clinical judgement for benefit determinations, including exceptions requests for a Medical Benefit Drug.
    EscalationIf a request falls outside a pharmacist's expertise, the determination is made in collaboration with a medical director.
    Preferred/Non-Preferred Drug — definition
    Preferred Drug — definitionThe drug of choice for CareSource for an FDA-approved use as indicated on a Pharmacy Policy Statement; designation based on clinical efficacy and cost as determined by the CareSource P&T Committee.
    Non-Preferred Drug — definitionA drug determined by CareSource to be less clinically efficacious or cost-effective for an FDA-approved use than other available drugs, as determined by the CareSource P&T Committee.
    Determining bodyDesignations are made by the CareSource Pharmacy & Therapeutics (P&T) Committee and reflected on CareSource policy/PDL resources.
    Specialty Drug — definition
    DefinitionA drug which treats highly complex diseases and/or requires special handling or distribution and is usually high cost.
    AuthorizationMany specialty drugs require prior authorization and may be dispensed at limited locations.
    Distribution/handlingMay require special handling or limited distribution channels; see CareSource's Specialty Drug List for specifics.

    Reauthorization / Continuation Criteria

    Reauthorization

    Reauthorization/continuation therapy is approved only when ALL of the following are documented:

    ALL of the following

    • Documentation of a positive clinical response to therapy
    • Documentation demonstrating member compliance with the prescribed therapy
    • Requested use and dosage remain consistent with FDA‑approved prescribing information (drug package insert)

    Site-of-Care Requirements

    Documentation Required

    Document appropriate site of care and rationale for medical‑benefit billing of self‑administered formulations

    Provide documentation that the drug will be administered in the appropriate site of care; if a self‑administered formulation is available and the drug is billed to the medical benefit, include rationale why the member cannot use the self‑administered version (self‑administered drugs are generally not covered under the medical benefit).

    • Document planned site of administration (e.g., infusion center) is appropriate
    • If a self‑administered dosage form exists, include rationale why the member cannot use it
    Policy Summary
    PayerCareSource
    PolicyMedical Benefit Drugs administrative policy
    Policy CodePolicy PAD-0898-AR-PASSE
    Change TypeNo material change
    Effective DateJul 1, 2026
    Last ReviewFeb 18, 2026
    Next Review Date
    Key ActionSubmit prior authorization requests with chart notes and member-specific documentation for each Medical Benefit Drug.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCoding ReferencesPrior Authorization, Authorization Period, and ReauthorizationDefinitionsReauthorization / Continuation CriteriaSite-of-Care Requirements